SCHEDULE 13D/A
SCHEDULE 13D/ASchedule 13D ownership disclosure
Actuate Therapeutics Inc
Common Stock, par value $0.000001 per share · CUSIP: 005083100
Event date: 2025-06-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOS FUND I, LPReported CIK 0001697316
Shares: 525,797.00 · Class: 2.6%
- BIOS FUND I QP, LPReported CIK 0001700297
Shares: 307,538.00 · Class: 1.5%
- BIOS FUND II, LPReported CIK 0001714576
Shares: 308,211.00 · Class: 1.5%
- BIOS FUND II QP, LPReported CIK 0001716869
Shares: 1,006,788.00 · Class: 4.9%
- BIOS FUND II NT, LPReported CIK 0001728851
Shares: 134,776.00 · Class: 0.7%
- BIOS FUND III, LPReported CIK 0001791917
Shares: 383,791.00 · Class: 1.9%
- BIOS FUND III QP, LPReported CIK 0001791916
Shares: 2,506,667.00 · Class: 12.3%
- BIOS FUND III NT, LPReported CIK 0001791910
Shares: 404,814.00 · Class: 2.0%
- BP DIRECTORS, LPReported CIK 0001813311
Shares: 116,801.00 · Class: 0.6%
- BIOS ACTUATE CO-INVEST I, LPReported CIK 0001771378
Shares: 300,749.00 · Class: 1.5%
- BIOS ACTUATE CO-INVEST II, LPReported CIK 0001825398
Shares: 2,094,650.00 · Class: 10.2%
- BIOS ACTUATE CO-INVEST III, LPReported CIK 0001956704
Shares: 573,394.00 · Class: 2.8%
- BIOS CLINICAL OPPORTUNITY FUND, LPReported CIK 0001988639
Shares: 1,259,427.00 · Class: 6.2%
- BIOS 2024 CO-INVEST, LPReported CIK 0002028708
Shares: 267,856.00 · Class: 1.3%
- BIOS EQUITY PARTNERS, LPReported CIK 0001813314
Shares: 950,136.00 · Class: 4.6%
- BIOS EQUITY PARTNERS II, LPReported CIK 0001813313
Shares: 1,750,524.00 · Class: 8.5%
- BIOS EQUITY PARTNERS III, LPReported CIK 0001831976
Shares: 5,963,316.00 · Class: 29.2%
- BIOS EQUITY COF, LPReported CIK 0002000747
Shares: 1,527,283.00 · Class: 7.4%
- CAVU MANAGEMENT, LPReported CIK 0001813270
Shares: 8,663,976.00 · Class: 42.2%
- BIOS CAPITAL MANAGEMENT, LPReported CIK 0001813845
Shares: 10,191,259.00 · Class: 49.5%
- CAVU ADVISORS, LLCReported CIK 0001813310
Shares: 8,663,976.00 · Class: 42.2%
- BIOS ADVISORS GP, LLCReported CIK 0001813844
Shares: 10,191,259.00 · Class: 49.5%
- LESLIE W. KREISReported CIK 0001813316
Shares: 8,733,351.00 · Class: 42.6%
- AARON G.L. FLETCHERReported CIK 0001789490
Shares: 10,267,232.00 · Class: 49.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-063957
- Form type
- SCHEDULE 13D/A
- Filer
- ACTUATE THERAPEUTICS, INC.
- CIK
- CIK 1652935
- Filed
- Jun 30, 2025
- Reporting period
- Jun 27, 2025
- Description
- Schedule 13D beneficial ownership